Search

everythinglearnresearchcommunity

for

Search:↓

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

The new drug delivery system effectively targets lung cancer cells.

Tadalafil and Finasteride may help treat aggressive melanoma.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Finasteride helps female-pattern hair loss.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

BMS-470539 reduces skin fibrosis and inflammation.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

GI197111X is best dissolved in Capmul MCM for trials.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

CTP-543 is generally safe for treating alopecia areata.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.